The most comprehensive national study to date has found that convalescent plasma appears to be safe to use on COVID-19 patients, a promising development in the race to find a treatment for the deadly virus. But the study didn’t determine whether the treatment works, NBC News reported. A team of more than 5,000 doctors from over 2,000 hospitals and laboratories…
Gilead Says Draft of Coronavirus Treatment Results Contains ‘Inappropriate Characterization' and Is ‘Inconclusive'
Gilead Sciences said that a draft document showing disappointing results from a closely watched clinical trial of the company’s treatment for the coronavirus contained “inappropriate characterizations” and that the study’s findings were “inconclusive.”
Zolgensma, a gene therapy infusion that costs $2.1 million dollars for the one time dose might save four-month-old Anthony Schmitz’s life. The drug has proven effective treating children under two with spinal muscular atrophy. (WTHR)